Education and Training
Menu

Jennifer L. Alejo, MD

Jennifer Alejo
Medical School: The University of Virginia Residency Program: New York University (NYU) Langone Health Undergraduate: The Johns Hopkins University

About Dr. Alejo

Dr. Alejo received her undergraduate degree from The Johns Hopkins University, where she met her incredibly loving and supportive husband, Sid. She received her medical degree from the University of Virginia. She completed three years of junior residency at Wake Forest, followed by two years of post-doctoral research fellowship studying COVID-19 vaccine outcomes in transplant recipients at Johns Hopkins. She then completed her General Surgery training at NYU in Manhattan. Jen is an aspiring surgeon-scientist with a goal of building an academic surgical practice after fellowship.

Education

2023 - 2025
Categorical and Chief Resident, General Surgery
New York University (NYU) Langone Health

2021 - 2023
T32 Research Fellowship, Transplantation
The Johns Hopkins University

2018 - 2021
Categorical Resident, General Surgery
Wake Forest University

2014 - 2018
MD - The University of Virginia

2013 - 2014
Research Program Coordinator
The WHOLE Donor Study - Long-Term Outcomes in Living Kidney Donors
Johns Hopkins Department of Surgery

2009 - 2013
BA - The Johns Hopkins University
History of Science, Medicine & Technology

Societies

11/2021 - present
Women in Transplantation (WIT) - Resident Member

8/2018 - present
American College of Surgeons (ACS) - Resident Member

3/2018 - present
Association of Women Surgeons (AWS) - Resident Member

6/2014 - present
American Society of Transplant Surgeons (ASTS) - Trainee Member

Awards

2025
Chief Resident Research Award
New York University Department of Surgery

2023
Association for Academic Surgery Outstanding Resident Research Award – Clinical Outcomes

2023
Society of Black Surgeons-Association for Academic Surgery Travel Award

2022
JHU Career Impact Award
The Johns Hopkins University

2018
R. Scott Jones Award in Surgery
University of Virginia Department of Surgery

2014
Director’s Dream Award
The Johns Hopkins Director of Residential Life

Research

During residency Dr. Alejo was awarded and NIH-funded T32 training grant to study COVID-19 vaccine responses and outcomes in solid organ transplant recipients. Her background also includes research in long-term outcomes of living kidney donors.

Publications

Original Peer-Reviewed Publications
  1. Johnston TS, Hage C, Abedon AT, Panda S, Alejo JL, Eby Y, Segev DL, Tobian AAR, Cox AL, Werbel WA, Karaba AH. Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients. Clin Infect Dis. 2024 Sep 26;79(3):652-655. doi: 10.1093/cid/ciae279. PubMed PMID: 38953683; PubMed Central PMCID: PMC11426267.
  2. Teles MS, Brundage J, Chiang TP, Alejo JL, Henriquez N, Wallwork R, Christopher-Stine L, Massie A, Segev DL, Connolly CM, Paik JJ, Werbel WA. Prevalence and Risk Factors of Postacute Sequelae of COVID-19 in Adults With Systemic Autoimmune Rheumatic Diseases. J Rheumatol. 2024 Sep 1;51(9):928-933. doi: 10.3899/jrheum.2023-1212. PubMed PMID: 38950954; PubMed Central PMCID: PMC11397179.
  3. Abedon AT, Chiang TPY, Karaba AH, Alejo JL, Chahoud M, Hussey C, Lopes JF, Hussain S, Larsen CP, Durand CM, Heeger PS, Segev DL, Clarke WA, Werbel WA. Letter to the editor: "hook" (prozone) effect in sars-cov-2 anti-spike binding antibody levels following vaccination, infection, or monoclonal antibody in solid organ transplant recipients. Clin Transplant. 2023 Aug;37(8):e15044. doi: 10.1111/ctr.15044. Epub 2023 Jun 17. PubMed PMID: 37329291; PubMed Central PMCID: PMC10528109.
  4. Chiang TP, Abedon AT, Alejo JL, Segev DL, Massie AB, Werbel WA. Incident COVID-19 and Hospitalizations by Variant Era Among Vaccinated Solid Organ Transplant Recipients. JAMA Netw Open. 2023 Aug 1;6(8):e2329736. doi: 10.1001/jamanetworkopen.2023.29736. PubMed PMID: 37594763; PubMed Central PMCID: PMC10439474.
  5. Thompson EA, Ngecu W, Stoddart L, Johnston TS, Chang A, Cascino K, Alejo JL, Abedon AT, Samaha H, Rouphael N, Tobian AA, Segev DL, Werbel WA, Karaba AH, Blankson JN, Cox AL. Heterologous versus homologous boosting elicits qualitatively distinct, BA.5-cross-reactive T cells in transplant recipients. JCI Insight. 2023 May 22;8(10). doi: 10.1172/jci.insight.168470. PubMed PMID: 37104041; PubMed Central PMCID: PMC10322695.
  6. Connolly CM, Karaba AH, Po-Yu Chiang T, Teles M, Kim JD, Scott Johnson T, Alejo JL, Segev DL, Christopher-Stine L, Werbel WA, Paik JJ. Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated patients with autoimmune disease. Clin Exp Rheumatol. 2023 May;41(5):1202-1203. doi: 10.55563/clinexprheumatol/pfli7o. Epub 2023 Feb 23. PubMed PMID: 36826787.
  7. Alejo JL, Kim JD, Chiang TPY, Avery RK, Karaba AH, Jefferis A, Warren DS, Massie AB, Tobian AAR, Segev DL, Werbel WA. Patient-reported outcomes after Tixagevimab and Cilgavimab pre-exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk. Clin Transplant. 2023 Apr;37(4):e14913. doi: 10.1111/ctr.14913. Epub 2023 Feb 1. PubMed PMID: 36651598; PubMed Central PMCID: PMC10089940.
  8. Alasfar S, Chiang TP, Snyder AJ, Ou MT, Boyarsky BJ, Abedon AT, Alejo JL, Cook S, Cochran W, Brigham E, Parker AM, Garonzik-Wang J, Massie AB, Brennan DC, Vannorsdall T, Segev DL, Avery RK. PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection. Transplantation. 2023 Jan 1;107(1):181-191. doi: 10.1097/TP.0000000000004340. Epub 2022 Sep 19. PubMed PMID: 36117251.
  9. Alejo JL, Ruck JM, Chiang TPY, Abedon AT, Kim JD, Avery RK, Tobian AAR, Warren DS, Levan ML, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipients. Clin Transplant. 2022 Sep 8;:e14818. doi: 10.1111/ctr.14818. [Epub ahead of print] PubMed PMID: 36073912.
  10. Alejo JL, Makary MA, Segev DL. Clinical Protection During the First Omicron Wave in Unvaccinated, Convalescent US Adults-Reply. JAMA. 2022 Jul 12;328(2):212-213. doi: 10.1001/jama.2022.10335. PubMed PMID: 35819425.
  11. Alejo JL, Chiang TPY, Mitchell J, Abedon AT, Jefferis AA, Werbel W, Massie AB, Makary MA, Segev DL. Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave. J Intern Med. 2022 Aug 10;. doi: 10.1111/joim.13555. [Epub ahead of print] PubMed PMID: 35946381.
  12. Karaba AH, Zhou W, Li S, Aytenfisu TY, Johnston TS, Akinde O, Eby Y, Abedon AT, Alejo JL, Qin CX, Thompson EA, Garonzik-Wang JM, Blankson JN, Cox AL, Bailey JR, Klein SL, Pekosz A, Segev DL, Tobian AAR, Werbel WA. Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients. Clin Infect Dis. 2022 Aug 12;. doi: 10.1093/cid/ciac652. [Epub ahead of print] PubMed PMID: 35959783; PubMed Central PMCID: PMC9384709.
  13. Alejo JL, Mitchell J, Chiang TP, Chang A, Abedon AT, Werbel WA, Boyarsky BJ, Zeiser LB, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Moore LW, Guha A, Huang HJ, Knight RJ, Gaber AO, Ghobrial RK, Garonzik-Wang JM, Segev DL, Bae SB. Predicting a Positive Antibody Response after 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach with External Validation. Transplantation. 2022 Jul 21;. doi: 10.1097/TP.0000000000004259. [Epub ahead of print] PubMed PMID: 35859275
  14. Strauss AT, Chang A, Alejo JL, Chiang TP, Hernandez NF, Zeiser LB, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients. Liver Transpl. 2022 Aug;28(8):1393-1396. doi: 10.1002/lt.26472. Epub 2022 May 9. PubMed PMID: 35389558
  15. Bae S, Alejo JL, Chiang TPY, Werbel WA, Tobian AAR, Moore LW, Guha A, Huang HJ, Knight RJ, Gaber AO, Ghobrial RM, McAdams-DeMarco MA, Segev DL. mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients. Am J Transplant. 2022 Jul 23;. doi: 10.1111/ajt.17158. PubMed PMID: 35869809
  16. Chang A, Strauss AT, Alejo JL, Chiang TP, Hernandez NF, Zeiser LB, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Warren DS, Garonzik-Wang JM, Massie AB, Werbel WA, Segev DL. Letter to the editor: Six-month antibody kinetics and durability in liver transplant recipients after two doses of SARS-CoV-2 mRNA vaccination. Hepatol Commun. 2022 Jul 5;. doi: 10.1002/hep4.2027. [Epub ahead of print] PubMed PMID: 35791054.
  17. Chang A, Mitchell J, Alejo JL, Chiang TPY, Abedon AT, Kim JD, Avery RK, Tobian AAR, Levan ML, Warren DS, Garonzik-Wang JM, Massie AB, Segev DL, Werbel WA. Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS-CoV-2 vaccines in solid organ transplant recipients: A case series. Clin Transplant. 2022 Jul 13;:e14772. doi: 10.1111/ctr.14772. [Epub ahead of print] PubMed PMID: 35822545
  18. Karaba AH, Johnston TS, Aytenfisu TY, Akinde O, Eby Y, Ruff JE, Abedon AT, Alejo JL, Blankson JN, Cox AL, Bailey JR, Klein SL, Pekosz A, Segev DL, Tobian AAR, Werbel WA. A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response. Transplantation. 2022 Jul 1;106(7):1440-1444. doi: 10.1097/TP.0000000000004140. Epub 2022 Apr 4. PubMed PMID: 35417115.
  19. Mitchell J, Alejo JL, Chiang TPY, Kim J, Chang A, Abedon AT, Avery RK, Tobian AAR, Massie AB, Levan ML, Warren DS, Garonzik-Wang JM, Segev DL, Werbel WA. Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update. Transplantation. 2022 Jul 1;106(7):e338-e340. doi: 10.1097/TP.0000000000004137. Epub 2022 Apr 15. PubMed PMID: 35426888.
  20. Teles MS, Connolly CM, Wallwork R, Frey S, Chiang TP, Alejo JL, Albayda J, Christopher-Stine L, Segev DL, Werbel WA, Paik JJ. Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series. Rheumatology (Oxford). 2022 Jun 27;. doi: 10.1093/rheumatology/keac370. [Epub ahead of print] PubMed PMID: 35758603.
  21. Frey S, Ruck JM, Alejo JL, Barker L, Matthew J, Werbel WA, Avery RK, Segev DL, Shah PD. Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary Report. Transplantation. 2022 Jun 14;. doi: 10.1097/TP.0000000000004240. [Epub ahead of print] PubMed PMID: 35698264
  22. Chang A, Chiang TP, Kim JD, Mitchell J, Alejo JL, Jefferis AA, Avery RK, Tobian AAR, Levan ML, Warren DS, Garonzik-Wang JM, Massie AB, Segev DL, Werbel WA. Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses. Clin Transplant. 2022 Jun 7;:e14738. doi: 10.1111/ctr.14738. [Epub ahead of print] PubMed PMID: 35670813.
  23. Alejo JL, Chiang TPY, Bowles Zeiser L, Kim JD, Mitchell J, Avery RK, Tobian AAR, Abedon RR, Levan ML, Warren DS, Garonzik-Wang JM, Massie AB, Segev DL, Werbel WA. Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave. Transplantation. 2022 Sep 1;106(9):e413-e415. doi: 10.1097/TP.0000000000004226 PubMed PMID: 35655363.
  24. Connolly CM, Frey S, Chiang TP, Teles M, Alejo JL, Albayda J, Shah AA, Werbel WA, Segev DL, Christopher-Stine L, Paik JJ. Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease. Rheumatology (Oxford). 2022 May 18;. doi: 10.1093/rheumatology/keac298. [Epub ahead of print] PubMed PMID: 35583259.
  25. Mitchell J, Connolly CM, Chiang TP, Alejo JL, Werbel WA, Segev DL, Massie AB. Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients. JAMA Netw Open. 2022 May 2;5(5):e2211897. doi: 10.1001/jamanetworkopen.2022.11897. PubMed PMID: 35576009.
  26. Alejo JL, Chiang TP, Mitchell J, Kim JD, Abedon AT, Karaba AH, Thomas L, Levan ML, Garonzik-Wang JM, Avery RK, Pekosz A, Clarke WA, Warren DS, Tobian AAR, Massie AB, Segev DL, Werbel WA. Brief Communication: Heterologous Ad.26.COV2.S versus Homologous BNT162b2/mRNA-1273 as a Third Dose in Solid Organ Transplant Recipients Seronegative After 2-Dose mRNA Vaccination. Am J Transplant. 2022 Apr 16;. doi: 10.1111/ajt.17061. [Epub ahead of print] PubMed PMID: 35429211. PubMed PMID: 35429211
  27. Abedon AT, Alejo JL, Kim JD, Thomas L, Mitchell J, Chiang TPY, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Six-month Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2022 May 1;106(5):e281-e283. doi: 10.1097/TP.0000000000004069. Epub 2022 Jan 19.
  28. Alejo JL, Mitchell J, Chang A, Chiang TPY, Massie AB, Segev DL, Makary MA. Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19. JAMA. 2022 Mar 15;327(11):1085-1087. doi: 10.1001/jama.2022.1393.
  29. Mitchell J, Kim J, Alejo JL, Chiang TP, Karaba AH, Blankson JN, Aytenfisu TY, Chang A, Abedon AT, Avery RK, Tobian AA, Massie AB, Levan ML, Warren DS, Garonzik-Wang JM, Segev DL, Werbel WA. Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2022 Mar 14;. doi: 10.1097/TP.0000000000004100. Epub 2022 Mar 3. PubMed PMID: 35289776.
  30. Mitchell J, Chiang TP, Alejo JL, Chang A, Abedon AT, Avery RK, Tobian AAR, Massie AB, Levan ML, Warren DS, Garonzik-Wang JM, Segev DL, Werbel WA. Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients. Transplantation. 2022 Mar 3;. doi: 10.1097/TP.0000000000004090. Epub 2022 Mar 3. PMID: 35250006.
  31. Strauss AT, Chang A, Alejo JL, Chiang TP, Hernandez NF, Zeiser LB, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Brief Report: SARS-CoV-2 Antibody Response to a Third Dose of Homologous mRNA Vaccination in Liver Transplant Recipients. Liver Transpl. 2022 Apr 7;. doi: 10.1002/lt.26472. [Epub ahead of print]
  32. Connolly CM, Chiang TP, Teles M, Frey S, Alejo JL, Massie A, Shah AA, Albayda J, Christopher-Stine L, Werbel WA, Segev DL, Paik JJ. Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases. Lancet Rheumatol. 2022 Mar 29;. doi: 10.1016/S2665-9913(22)00065-0.
  33. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Improved Antibody Response After a Fifth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2022 Feb 15;. doi: 10.1097/TP.0000000000004092. Epub 2022 Mar 14.
  34. Connolly CM, Teles M, Frey S, Boyarsky BJ, Alejo JL, Werbel WA, Albayda J, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ. Booster-dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series. Ann Rheum Dis. 2022 Feb;81(2):291-293. doi: 10.1136/annrheumdis-2021-221206. Epub 2021 Sep 7.
  35. Connolly CM, Chiang TP, Boyarsky BJ, Ruddy JA, Teles M, Alejo JL, Massie A, Werbel WA, Shah AA, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ. Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series. Ann Rheum Dis. 2022 Feb;81(2):293-295. doi: 10.1136/annrheumdis-2021-221252. Epub 2021 Sep 23.
  36. Alejo JL, Chang A, Abedon AT, Mitchell J, Chiang TP, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2022 Feb 1;106(2):e161-e162. doi: 10.1097/TP.0000000000003991.
  37. Alejo JL, Abedon AT, Kim JD, Thomas L, Mitchell J, Chiang TPY, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. 6-mo Antibody Kinetics and Durability After 3 Doses of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2022 Jan 19;. doi: 10.1097/TP.0000000000004069. [Epub ahead of print]
  38. Frey S, Chiang TP, Connolly CM, Teles M, Alejo JL, Boyarsky BJ, Christopher-Stine L, Werbel WA, Massie AB, Segev DL, Paik JJ. Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease. Lancet Rheumatol. 2022 Jan 18;. doi: 10.1016/S2665-9913(21)00417-3. [Epub ahead of print]
  39. Teles M, Connolly CM, Frey S, Chiang TP, Alejo JL, Boyarsky BJ, Shah AA, Albayda J, Christopher-Stine L, Werbel WA, Segev DL, Paik JJ. Attenuated response to fourth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series. Ann Rheum Dis. 2022 Jan 17;. doi: 10.1136/annrheumdis-2021-221641. [Epub ahead of print]
  40. Alejo JL, Mitchell J, Chiang TP, Abedon AT, Sidoti CN, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Warren DS, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2022 Jan 1;106(1):e109-e110. doi: 10.1097/TP.0000000000003975.
  41. Karaba AH, Zhu X, Liang T, Wang KH, Rittenhouse AG, Akinde O, Eby Y, Ruff JE, Blankson JN, Abedon AT, Alejo JL, Cox AL, Bailey JR, Thompson EA, Klein SL, Warren DS, Garonzik-Wang JM, Boyarsky BJ, Sitaras I, Pekosz A, Segev DL, Tobian AAR, Werbel WA. A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients. Am J Transplant. 2021 Dec 24;. doi: 10.1111/ajt.16933. [Epub ahead of print]
  42. Karaba AH, Johnston TS, Aytenfisu TY, Akinde O, Eby Y, Ruff JE, Abedon AT, Alejo JL, Blankson JN, Cox AL, Bailey JR, Klein SL, Pekosz A, Segev DL, Tobian AAR, Werbel WA. A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response. Transplantation. 2022 Apr 4;. doi: 10.1097/TP.0000000000004140. [Epub ahead of print]
  43. Alejo JL, Mitchell J, Chiang TP, Abedon AT, Boyarsky BJ, Avery RK, Tobian AAR, Levan ML, Massie AB, Garonzik-Wang JM, Segev DL, Werbel WA. Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Transplantation. 2021 Dec 1;105(12):e280-e281. doi: 10.1097/TP.0000000000003934.
  44. Frey S, Connolly CM, Chiang TP, Teles M, Alejo JL, Boyarsky BJ, Christopher-Stine L, Werbel WA, Segev DL, Paik JJ. Antibody kinetics in patients with rheumatic diseases after SARS-CoV-2 mRNA vaccination. Lancet Rheumatol. 2021 Nov;3(11):e753-e754. doi: 10.1016/S2665-9913(21)00282-4. Epub 2021 Sep 28.
  45. Chiang TP, Connolly CM, Ruddy JA, Boyarsky BJ, Alejo JL, Werbel WA, Massie A, Christopher-Stine L, Garonzik-Wang J, Segev DL, Paik JJ. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 Oct;80(10):1365-1366. doi: 10.1136/annrheumdis-2021-221145. Epub 2021 Aug 24.
  46.  Gurung K, Alejo J, Rogers J, Farney AC, Orlando G, Jay C, Reeves-Daniel A, Mena-Gutierrez A, Sakhovskaya N, Doares W, Kaczmorski S, Gautreaux M, Stratta RJ. Recipient age and outcomes following simultaneous pancreas-kidney transplantation in the new millennium: Single-center experience and review of the literature. Clin Transplant. Aug;35(8):e14302. doi: 10.1111/ctr.14302. Epub 2021 Apr 16. Review.
  47. Shahbazov R, Maluf D, Azari F, Hakim D, Martin O, Dicocco P, Alejo JL, Saracino G, Hakim N. Laparoscopic Versus Finer-Assisted Open Donor Nephrectomy Technique: A Possible Safe Alternative. Exp Clin Transplant. 2020 Oct;18(5):585-590. doi: 10.6002/ect.2019.0115. Epub 2019 Sep 16.
  48. Shahbazov R, Fox M, Alejo JL, Anjum MA, Azari F, Doyle A, AgarwalA, Brayman KL. A case of rhabdomyolysis after kidney transplantation successfully managed with intensive continuous dialysis. J Surg Case Rep. 2018 Apr 30;2018(4):rjy078.
  49. Shahbazov R, Talanian M, Alejo JL, Azari F, Agarwal A, Brayman KL. Surgical Management of Encapsulating Peritoneal Sclerosis: A Case Report in Kidney Transplant Patient. Case Rep Surg 2018 Feb 21;2018:4965459.
  50. Alejo JL, Luo X, Massie AB, Henderson ML, DiBrito SR, Locke JE, Purnell T, Boyarsky BJ, Anjum S, Halpern SE, Segev DL. Patterns of physician utilization before and after living kidney donation. Clin Transplant 2017 Jul;31(7): 10.1111/ctr.12992.
  51. Fahmy LM, Massie AB, Muzaale AD, Bagnasco SM, Orandi BJ, Alejo JL, Boyarsky BJ, Anjum SK, Montgomery RA, Dagher NN, Segev DL. Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation. Transplantation, 2016 Jun;100(6):1294-8.
  52. Massie AB, Luo X, Alejo JL, Poon AK, Cameron AM, Segev DL. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy. Liver Transplantation, 2015 May;21(5):683-9.
  53. Boyarsky BJ, Massie AB, Alejo J, Van Arendonk KJ, Wildonger S, Garonzik-Wang JM, Montgomery RA, Deshpande NA, Segev DL. Experiences Obtaining Insurance After Live Kidney Donation. American Journal of Transplantation, 2014 Sep;14(9)2168-72.
  54. Massie AB, Luo X, Chow EKH, Alejo JL, Desai NM, Segev DL. Survival Benefit of Primary Deceased Donor Transplantation With High-KDPI Kidneys. American Journal of Transplantation, 2014 Act;14(10):2310-6.
  55. Arnaoutakis GJ, Bittle GJ, Allen JG, Weiss ES, Alejo J, Baumgartner WA, Shah AS, Wolfgang CL, Efron DT, and Conte JV. General and Acute Care Surgical Procedures in Patients with Left Ventricular Assist Devices. World Journal of Surgery, 2014 Apr;38(4):765-73.
  56. Alejo, JL., George, TJ., Beaty, CA., Allaf, ME., Black JH., Shah, AS. Novel Approach to Recurrent Cavoatrial Renal Cell Carcinoma. Annals of Thoracic Surgery 2012 May; 93(5):e119-21.
Share This Page:
Post Tweet